̽»¨ºÏ¼¯

Solid form screening and selection is an integral part of drug development.

Quality by Design (QbD) is well established in the pharmaceutical industry for manufacturing processes, including active pharmaceutical ingredients and drug products.

This article outlines the preclinical studies to assess and manage developability risks of NMEs for oral drug products

Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes.

How to create a development strategy that bridges gaps earlier in the process to make the transition smoother.

Lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules

Characterization of the micronized drug is important to understand its bulk properties and design downstream processes and manufacturing approaches.

Clarifying the myths surrounding LBDSS which may make drug developers consider it in parallel to other formulation approaches

Stability is a critical quality attribute of pharmaceutical products

Current critical issues facing the oral solid dose manufacturing industry